OrthoPediatrics Corp (KIDS) stock
KIDSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/305% below fair value
$31.74−0.77 (-2.37%)
Close on Nov 20, 2026Market cap $828.75MP/E –Yield –
OrthoPediatrics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
OrthoPediatrics's revenue for the twelve months ending Sep 30, 2026 was $264.14M, up 16.1% year over year. For fiscal 2025 it was $236.35M, up 15.4% from the year before. Over ten years it grew 22.5% a year on average. The highest annual figure on record is $236.35M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $236.35M | +15.4% |
| FY2024 | Dec 31, 2024 | $204.73M | +37.6% |
| FY2023 | Dec 31, 2023 | $148.73M | +21.6% |
| FY2022 | Dec 31, 2022 | $122.29M | +24.7% |
| FY2021 | Dec 31, 2021 | $98.05M | +37.9% |
| FY2020 | Dec 31, 2020 | $71.08M | -2.0% |
| FY2019 | Dec 31, 2019 | $72.55M | +26.0% |
| FY2018 | Dec 31, 2018 | $57.56M | +26.2% |
| FY2017 | Dec 31, 2017 | $45.62M | +22.3% |
| FY2016 | Dec 31, 2016 | $37.30M | +20.3% |
| FY2015 | Dec 31, 2015 | $31.00M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $72.66M | +18.6% |
| Q2 FY2026 | Jun 30, 2026 | $70.51M | +15.4% |
| Q1 FY2026 | Mar 31, 2026 | $59.36M | +13.3% |
| Q4 FY2025 | Dec 31, 2025 | $61.61M | +17.0% |
| Q3 FY2025 | Sep 30, 2025 | $61.25M | +12.2% |
| Q2 FY2025 | Jun 30, 2025 | $61.08M | +15.7% |
| Q1 FY2025 | Mar 31, 2025 | $52.41M | +17.3% |
| Q4 FY2024 | Dec 31, 2024 | $52.67M | +40.0% |
| Q3 FY2024 | Sep 30, 2024 | $54.57M | +36.5% |
| Q2 FY2024 | Jun 30, 2024 | $52.80M | +33.5% |
| Q1 FY2024 | Mar 31, 2024 | $44.69M | +41.5% |
| Q4 FY2023 | Dec 31, 2023 | $37.61M | +21.4% |
| Q3 FY2023 | Sep 30, 2023 | $39.97M | +14.4% |
| Q2 FY2023 | Jun 30, 2023 | $39.56M | +20.1% |
| Q1 FY2023 | Mar 31, 2023 | $31.59M | +34.9% |
| Q4 FY2022 | Dec 31, 2022 | $30.99M | +24.9% |
| Q3 FY2022 | Sep 30, 2022 | $34.95M | +39.4% |
| Q2 FY2022 | Jun 30, 2022 | $32.93M | +23.3% |
| Q1 FY2022 | Mar 31, 2022 | $23.42M | +9.1% |
| Q4 FY2021 | Dec 31, 2021 | $24.81M | +31.1% |
| Q3 FY2021 | Sep 30, 2021 | $25.08M | +12.9% |
| Q2 FY2021 | Jun 30, 2021 | $26.70M | +96.4% |
| Q1 FY2021 | Mar 31, 2021 | $21.46M | +31.2% |
| Q4 FY2020 | Dec 31, 2020 | $18.92M | -0.1% |
| Q3 FY2020 | Sep 30, 2020 | $22.21M | +7.0% |
| Q2 FY2020 | Jun 30, 2020 | $13.59M | -25.3% |
| Q1 FY2020 | Mar 31, 2020 | $16.36M | +11.6% |
| Q4 FY2019 | Dec 31, 2019 | $18.95M | +30.1% |
| Q3 FY2019 | Sep 30, 2019 | $20.74M | +31.1% |
| Q2 FY2019 | Jun 30, 2019 | $18.20M | +20.7% |
| Q1 FY2019 | Mar 31, 2019 | $14.66M | +21.2% |
| Q4 FY2018 | Dec 31, 2018 | $14.57M | +24.7% |
| Q3 FY2018 | Sep 30, 2018 | $15.82M | +27.8% |
| Q2 FY2018 | Jun 30, 2018 | $15.08M | +27.7% |
| Q1 FY2018 | Mar 31, 2018 | $12.09M | +23.9% |
| Q4 FY2017 | Dec 31, 2017 | $11.68M | +24.0% |
| Q3 FY2017 | Sep 30, 2017 | $12.38M | – |
| Q2 FY2017 | Jun 30, 2017 | $11.80M | – |
| Q1 FY2017 | Mar 31, 2017 | $9.76M | – |
| Q4 FY2016 | Dec 31, 2016 | $9.42M | – |
See a number that looks wrong?